Desferrioxamine-induced long bone changes in thalassaemic patients - Radiographic features, prevalence and relations with growth

Clinical Radiology

Volumn 55, Issue 8, 2000, Pages 610-614

  Chan, Y L ^a   Li, C K ^b   Pang, L M ^a   Chik, K W ^b  

^a Departments of Diagnostic Radiology and Organ Imaging   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone dysplasia; Deferoxamine; Desferrioxamine; Iron chelation; Thalassaemia

Indexed keywords

DEFEROXAMINE; FERRITIN; IRON;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; BLOOD TRANSFUSION; BODY HEIGHT; BONE AGE; BONE DEFECT; BONE DYSPLASIA; BONE GROWTH; BONE RADIOGRAPHY; CHELATION THERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG INDUCED DISEASE; FEMALE; GROWTH INHIBITION; HAND; HUMAN; IMAGE ANALYSIS; INCIDENCE; IRON OVERLOAD; LONG BONE; MALE; PREVALENCE; PRIORITY JOURNAL; RADIODIAGNOSIS; THALASSEMIA; TREATMENT OUTCOME;

EID: 0034520518     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1053/crad.2000.0492     Document Type: Article

References (18)

1. Early iron overload in beta-thalassaemia major: When to start chelation therapy?
2. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions
3. Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia
4. Deferoxamine-induced growth retardation in patients with thalassemia major
5. Deferoxamine-induced bone dysplasia in patients with thalassemia major
6. Growth failure and bony changes induced by deferoxamine
7. Growth plate injury of the long bones in treated thalassemia
8. Long-term follow-up of skeletal dysplasia in thalassaemia major
9. Limb deformity and metaphyseal abnormalities in thalassaemia major
10. Growth hormone secretion and bone histomorphometric study in thalassaemic patients with acquired skeletal dysplasia secondary to desferrioxamine
11. Metaphyseal abnormalities in children: Pathophysiology and radiologic appearance
12. In vitro and in vivo effects of deferoxamine in neonatal acute leukemia
13. Myoglobin inhibits proliferation of cultured human proximal tubular (HK-2) cells
14. Effect of deferoxamine on DNA synthesis. DNA repair, cell proliferation, and differentiation of HL-60 cells
15. Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation
16. Evaluating the effect of desferrioxamine on bone cell proliferation
17. Suppression of HL-60 cell proliferation by desferrioxamine: Changes in c-myc expression